One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 350,000 shares of Pfizer Inc. (NYSE: PFE) on Friday, as the price of this fund was up over 2% in the day’s session. It is also up a fair amount in the past year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) added 351,289 shares of Pfizer. At Friday’s closing price, this would have valued this purchase at roughly $16.4 million. This is only a small fraction of the total holdings. The fund is up 42% over the past 52 weeks.
Check out all the ARK Invest buys for Friday:
Fund | Ticker | Name | Shares |
---|---|---|---|
ARKF | JD | JD.COM | 38,130 |
ARKF | PDD | PINDUODUO | 62,767 |
ARKF | TDOC | TELADOC HEALTH | 4,793 |
ARKG | PFE | PFIZER | 351,289 |
ARKG | QSI | QUANTUM-SI | 1,818 |
ARKG | FATE | FATE THERAPEUTICS | 57,841 |
ARKG | DYNS | DYNAMICS SPECIAL PURPOSE | 49,500 |
ARKG | RPTX | REPARE THERAPEUTICS | 7,501 |
ARKG | ADPT | ADAPTIVE BIOTECHNOLOGIES | 1,000 |
ARKG | PSNL | PERSONALIS | 5,444 |
ARKK | SGFY | SIGNIFY HEALTH | 190,400 |
ARKK | FATE | FATE THERAPEUTICS | 114,617 |
ARKQ | ACIC | ATLAS CREST INVESTMENT | 190,900 |
ARKQ | KTOS | KRATOS DEFENSE & SECURITY SOLUTIONS | 59,400 |
ARKQ | KMTUY | KOMATSU | 17,000 |
ARKW | GENI | GENIUS SPORTS | 69,647 |
ARKX | PRNT | 3D PRINTING ETF | 11,293 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
It’s Your Money, Your Future—Own It (sponsor)
Retirement can be daunting, but it doesn’t need to be.
Imagine having an expert in your corner to help you with your financial goals. Someone to help you determine if you’re ahead, behind, or right on track. With SmartAsset, that’s not just a dream—it’s reality. This free tool connects you with pre-screened financial advisors who work in your best interests. It’s quick, it’s easy, so take the leap today and start planning smarter!
Don’t waste another minute; get started right here and help your retirement dreams become a retirement reality.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.